Status:
COMPLETED
Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Lead Sponsor:
Endeavor Health
Collaborating Sponsors:
GE Healthcare
Conditions:
Traumatic Brain Injury
Parkinson's Disease
Eligibility:
All Genders
18-100 years
Brief Summary
The purpose of this study is to learn if a new brain imaging technology called DaTscan can detect subtle changes in the brain that are similar to those seen in early Parkinson's disease (PD). The resu...
Detailed Description
This study is being done to learn if a new brain imaging technology called DaTscan can detect subtle changes in the brain ("biomarkers") that are similar to those seen in early Parkinson's disease (PD...
Eligibility Criteria
Inclusion
- mTBI or mTBI- survey respondents
- Ages 18-100 years
- Without a history of parkinsonism or tremor
Exclusion
- History of parkinsonism or tremor
- Lugol or iodide allergy
- Contraindicated medications for DaTscan
- Pregnancy or nursing mothers
- Renal or liver impairment
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT01516281
Start Date
March 1 2012
End Date
December 1 2015
Last Update
July 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NorthShore University HealthSystem
Evanston, Illinois, United States, 60201